Medicure Reports First Quarter 2012 Financial Results
Medicure reported a first-quarter profit of $23.5 million, reversing a year-ago net loss of $1.6 million as it booked a $23.9-million non-cash gain on a debt settlement.
Medicure reported a first-quarter profit of $23.5 million, reversing a year-ago net loss of $1.6 million as it booked a $23.9-million non-cash gain on a debt settlement.
The $50 million Agricultural Innovation Program, which will boost the development and commercialization of innovative new products, technologies and processes in the agricultural sector was announced by Agriculture Minister Gerry Ritz.
GSK announced the launch of a new national fund that will significantly advance the commercialization of scientific innovation in Canada by investing in early stage breakthrough research.
Wendy Smith, a local prosthetist whose quest to build a better breast for women who have undergone a full or partial mastectomy just got a $97,000 financial boost from the federal government.
Last week, Burt Rutan, named Entrepreneur of the Year by Inc. magazine and one of "the world's 100 most influential people" by Time magazine, imparted some innovation tips to a Winnipeg audience with a vested interest in triggering more innovation-based e
Business incubators are designed to help technology companies grow in all sorts of ways.
Serious players in the biomaterials and bioenergy fields from around the world have converged on Winnipeg for the three-day BIOFIBE2011 Conference.
Medicure Inc. is pleased to announce that the TSX Venture Exchange has granted approval for Medicure to graduate from the NEX, to the TSX Venture Exchange as a Tier 2 issuer.
Ottawa needs to overhaul its flagship R & D program because it spends too much money and fails to show any increase in innovation among Canadian companies, says a federally appointed panel of experts.
As part of Small Business Week, the province is unveiling two new programs, AccessManitoba and Business Programs and Services (BizPaS) to help support small businesses and entrepreneurs set up shop, access services and provide better customer service, Ent
The LSAM Awards Gala was held on October 5, 2011 at the Hotel Fort Garry. Click on the link for a full list of this year’s winners.
The Emerging Life Science Company of the Year award celebrates a company based in Manitoba that is recognized for their growth potential.
Miraculins announced that it has completed an Exclusive Manufacturing and Supply Agreement with Thermo Fisher Scientific Inc.
IMRIS announced that the first published results on the early clinical experiences at hospitals using the IMRIS system, highlight a number of positive findings for procedures and patient outcomes resulting from utilization of the intraoperative MRI capabi
Ag-West Bio leads study to evaluate feasibility of developing crops and processing for bio-jet fuels
Information on the Demonstration and Research and Development funding program Presented by Marc D’Iorio
Theo Wigle, a grade 12 student at Winnipeg’s Shaftesbury High School, was the winner of the 2011 Biotechnology Brain Game
The board of Cold-FX flu remedy maker Afexa Life Sciences Inc. has given its final stamp of approval to a friendly $76-million takeover bid by Valeant Pharmaceuticals International Inc.
Close to 20 positions have been eliminated from the National Research Council's operations in Winnipeg.
Kane Biotech Inc. is pleased to announce the invention and patenting of a new bone tissue regenerating fusion peptide based on the Company’s competence stimulating peptide oral care technology.
IMRIS announced the sale of two systems to a single confidential U.S. customer.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.